Published in Medical Letter on the CDC and FDA, October 31st, 2010
"This analysis permits to evaluate the effectiveness of preventive measures taken after the prevalence survey in year Y. It also analyzes the robustness of the SVM algorithm...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.